In this blog post I suggest a major therapeutic change in the initial approach to the bipolar patient. Electroconvulsive therapy is usually regarded as the last treatment choice for a number of psychiatric conditions, including bipolar disorder. There is, however, evidence that supports an earlier application of this technique.
Source: Matt Snyders. Citypages, Wednesday, May 20, 2019
The Effectiveness of Early Electroconvulsive Therapy
in the Treatment of Bipolar Disorder
Angelo Juarez
Bipolar disorder (BD) is a challenging health condition, as it is very difficult to manage, and current treatments must take place over the course of years to attain desired results. Aside from having various side effects, mood stabilizers render ineffective for many bipolar patients, and ongoing research suggests multimodality treatments have better results than drug therapy or psychotherapy alone, yet very often clinicians prefer the use of these unimodal therapeutic protocols, without achieving definitive clinical progress (Comer, 2015). Additionally, the efficacy of combined treatment, including three or more drugs, is not evidence-based, and there are concerns as it might be associated with increased switches rate, rapid cycling, treatment resistance and a higher rate of user nonadherence. Another treatment, electroconvulsive therapy (ECT), is currently a medical procedure used as a last resource for critical or refractory bipolar disorder. This practice has been criticized by a number of experts, because of the extended suffering (lasting up to years) caused by ineffective multidrug treatments, which, in turn, is linked to poor ECT outcome (Perugi, Medda, Toni, Giorgi Mariani, Socci, Mauri, 2017). The early implementation of electroconvulsive therapy, concomitant with pharmacotherapy and adjunctive psychotherapy can, in fact, be more advantageous than its use in the late stages of bipolar disorder.
ECT has been traditionally employed for chronic or recalcitrant psychiatric conditions, such as severe depression, treatment-resistant depression, severe mania, catatonia, agitation and aggression in people with dementia, and it is used as a first-line treatment only in extreme cases, such as those of suicidal ideation and behavior, emaciation, exhaustion from prolonged depressive or manic episodes, severe mixed state and catatonia (Hall-Flavin, 2018). Schoeyen and colleagues (2009), in a multicenter, unblinded randomized controlled clinical trial, performed at seven acute-care psychiatric inpatient clinics from Norway, found that ECT was substantially more effective than the Goodwin and Jamison algorithm-based pharmacological treatment, consisting of antipsychotics, anticonvulsants, lithium, and antidepressants (intention-to-treat efficacy group N = 73 BD I or II patients, 26-79 yr.; ECT group n=36; algorithm-based pharmacological treatment group n=30). Patients non-responsive to previous treatment were excluded from the study, which comprised three weekly sessions for up to six weeks, and treatment effectiveness was determined using the Montgomery-Åsberg Depression Rating Scale, the 30-item version of the Inventory of Depressive Symptomatology — Clinician-Rated, and the Clinical Global Impression for Bipolar Disorder test, finding that ECT subjects scored lower than the pharmacological treatment group on all tests (by 6.6 points – 95% CI SE=2.05, 9.4 points – 95% CI SE=2.49, and 0.7 points – 95% CI SE=0.31, respectively), after the six-week trial. The response rate was also higher for the ECT group (73.9% vs. 35.0%), but the remission rate did not differ significantly between groups (34.8% vs. 30.0%), and BP I and II did not differ in response to ECT. This finding not only suggests ECT can be advantageous in the earlier stages of BD, but also situates ECT as an alternative for BD over mood stabilizers.
In a similar Italian study, done in a large sample of bipolar patients with drug-resistant depression, mania, mixed state and catatonia (N=522), Perugi and colleagues (2017) found that 68.8% responded to ECT (specifically 68.1% for BD depression, 72.9% for mixed state, 75% for mania and 80.8% for catatonia), while length of current episode (backward stepwise logistic regression: OR = 1.028; 95% CI = 1.01 to 1.05; P = 0.002) and global severity of illness (CGIs baseline total mean score: OR = 1.75; 95% CI= 1.06 to 2.89; P = 0.030) were statistically significant predictors of nonresponse. This evidence suggests that, if used early in the course of BD, ECT may have a more advantageous effect in patients.
Other studies suggest that, ECT is more effective in bipolar than unipolar depression (Daly et al, 2001; Sienaert, Vansteelandt, Demyttenaere & Peuskens, 2009). For instance, in a Belgian randomized clinical trial performed by Sienaert and colleagues (2009), it was found that patients with bipolar and unipolar depression did not differ in rates of response or remission after application of ECT, neither in their reaction to unilateral or bifrontal ECT. However, the study also showed there was a faster response to ECT among BD depressed patients than in unipolar depression patients. (N=64; unipolar depression subjects, n=51, 79.7%; bipolar depression subjects, n=13, 20.3%).
These studies have shown that ECT can have a widespread use among those who suffer BD. There are several problems associated with this practice, though. Current stigma associated with the use of ECT discourages many patients from choosing this alternative treatment, as in the past it was performed at higher voltages and without anesthesia. Due to this bad fame health care providers will have to promote the virtues and safety of ECT. On the other hand, many psychiatrists may be used to their current protocols. Changing the view and approach of a treatment might even require decades. Finally, and to the dislike of optimistic mental health providers, it is important to realize the that, in general, current therapies to treat bipolar disorder, among other psychiatric conditions, are still in an early stage of development. This is proved by the widespread ineffectiveness these therapies have among patients, by the unspecificity of current medications (side effects), and by the rare cases in which one could say these pathologies have been ultimately cured. Regardless of extensive scientific study on the matter, most biochemical and physiological processes taking place within different brain areas, which ultimately result in what we know as the mind, remain a mystery. Both the structuralist and functionalist psychological schools of thought could not prevail as dominant models because of their inability to elucidate mental processes from a physio-anatomical standpoint. Because of this lack of understanding clinicians and scientists are mostly able to work based on clinical signs and symptoms, being incapable of foresee a potential psychiatric abnormality before it actually presents. Maybe one day psychiatric diseases like schizophrenia, Parkinson’s disease and bipolar disorder will be treated in a definitive manner, but until that day, patients will have to receive the most comprehensive, multidisciplinary treatments, in order to improve their quality of life and help them cope with their mental ailments.
References
Comer, R.J. (2015). Abnormal Psychology (9th edition). New York, NY: Worth Publishers.
Daly, J., Prudic, J., Devanand, D., Nobler, M., Lisanby, S., Peyser, S., Roose, S. & Sackeim, H. (2001). ECT in bipolar and unipolar depression: differences in speed of response. Bipolar Disorsers. 3:95-104. doi: 10.1034/j.1399-5618.2001.030208.x.
Hall-Flavin, D. (2018, October 12). Electroconvulsive therapy (ECT). Retrieved from https://www.mayoclinic.org/tests-procedures/electroconvulsive-therapy/about/pac-20393894.
Perugi, G., Medda, P., Toni, C., Giorgi Mariani, M., Socci, C. & Mauri, M. (2017). The Role of Electroconvulsive Therapy (ECT) in Bipolar Disorder: Effectiveness in 522 Patients with Bipolar Depression, Mixed-state, Mania and Catatonic Features. Current Neuropharmacology. 15:359-371. doi: 10.2174/1570159X14666161017233642.
Sienaert, P., Vansteelandt, K., Demyttenaere, K. & Peuskens, J. (2009). Ultra-brief pulse ECT in bipolar and unipolar depressive disorder: differences in speed of response. Bipolar Disorders. 11:418-424. doi: 10.1111/j.1399-5618.2009.00702.x.